Skip to main content

Babak Azad

Equibles does not estimate personal net worth.

About Babak Azad

GoodRx Holdings, Inc. reported in an 8-K filed July 27, 2023 that Babak Azad was terminated as Chief Marketing Officer and SVP, Marketing & Communications, effective July 7, 2023. GoodRx Holdings, Inc. reported in an 8-K filed June 27, 2023 that Babak Azad was terminated as Chief Marketing Officer, effective July 7, 2023. The proxy statement of GoodRx Holdings, Inc. reports total compensation of $2,209,197 for Babak Azad in fiscal 2022, including a base salary of $366,500. Disclosed compensation is on record for 4 fiscal years.

“As previously disclosed, on June 27, 2023, GoodRx Holdings, Inc. (the "Company") determined that Babak Azad would no longer serve as Chief Marketing Officer and SVP, Marketing & Communications of the Company, effective July 7, 2023 (the "Separation Date").”
GoodRx Holdings, Inc. Form 8-K, filed July 27, 2023 · Read the filing
“On June 27, 2023, GoodRx Holdings, Inc. (the "Company") determined that Babak Azad will no longer serve as Chief Marketing Officer, effective July 7, 2023 (the "Effective Date").”
GoodRx Holdings, Inc. Form 8-K, filed June 27, 2023 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 GoodRx Holdings, Inc. (GDRX) $366,500 $2,209,197
2021 GoodRx Holdings, Inc. (GDRX) $333,000 $500,397
2020 GoodRx Holdings, Inc. (GDRX) $325,000 $2,382,375
2019 GoodRx Holdings, Inc. (GDRX) $73,958 $220,337

Recent activity